Valuation: The Cooper Companies, Inc.

Capitalization 19.81B 18.82B 17.49B 15.51B 28.08B 1,681B 31.05B 217B 80.07B 690B 74.37B 72.76B 3,010B P/E ratio 2025 *
33x
P/E ratio 2026 * 28.2x
Enterprise value 21.65B 20.57B 19.11B 16.95B 30.7B 1,838B 33.94B 237B 87.52B 755B 81.29B 79.53B 3,290B EV / Sales 2025 *
5.24x
EV / Sales 2026 * 4.79x
Free-Float
91.2%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.18%
1 week-3.81%
Current month-5.15%
1 month-4.50%
3 months-8.28%
6 months+4.98%
Current year+4.72%
More quotes
1 week
97.24
Extreme 97.24
106.63
1 month
97.24
Extreme 97.24
106.63
Current year
84.76
Extreme 84.76
112.38
1 year
83.45
Extreme 83.453
112.38
3 years
61.05
Extreme 61.0538
112.38
5 years
59.17
Extreme 59.1688
115.90
10 years
29.82
Extreme 29.82
115.90
More quotes
Director TitleAgeSince
Chief Executive Officer 54 2018-04-30
Director of Finance/CFO 45 2018-04-30
Chief Operating Officer 59 2013-10-31
Manager TitleAgeSince
Director/Board Member 54 2018-04-30
Chairman 77 2021-03-22
Director/Board Member 61 2016-03-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.18%-3.81%+18.30%-2.97%19.81B
-1.44%-1.82%+24.03%+21.97%111B
-0.42%-2.54%+20.57%-3.70%43.09B
+0.13%+6.86%+120.32%-49.57%2.83B
+1.24%-2.20%-14.99%-68.93%2.39B
-0.08%-0.28%+3.19% - 1.09B
+3.55%-2.28%-9.33%-13.21%847M
+2.42%+0.26%-35.34%-60.67%747M
-1.52%-7.17%+105.40% - 721M
+0.48%-2.76%-26.69%-15.93%550M
Average +0.42%-2.16%+20.55%-24.13% 18.29B
Weighted average by Cap. -0.95%-1.32%+23.22%+10.20%
See all sector performances

Financials

2025 *2026 *
Net sales 4.13B 3.92B 3.65B 3.24B 5.86B 351B 6.48B 45.32B 16.7B 144B 15.51B 15.18B 628B 4.4B 4.18B 3.89B 3.45B 6.24B 373B 6.9B 48.27B 17.79B 153B 16.52B 16.16B 669B
Net income 579M 550M 511M 453M 821M 49.13B 908M 6.35B 2.34B 20.18B 2.17B 2.13B 87.98B 700M 665M 618M 548M 992M 59.39B 1.1B 7.68B 2.83B 24.4B 2.63B 2.57B 106B
Net Debt 1.84B 1.75B 1.63B 1.44B 2.61B 156B 2.89B 20.22B 7.45B 64.27B 6.92B 6.77B 280B 1.26B 1.2B 1.12B 989M 1.79B 107B 1.98B 13.86B 5.11B 44.05B 4.74B 4.64B 192B
More financial data * Estimated data
Logo The Cooper Companies, Inc.
The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.
Employees
16,000
More about the company
Date Price Change Volume
24-12-10 99.08 $ -0.18% 1,574,467
24-12-09 99.26 $ +0.57% 1,724,737
24-12-06 98.70 $ -4.39% 3,694,044
24-12-05 103.23 $ -1.67% 1,850,052
24-12-04 104.98 $ +1.64% 2,071,297

Delayed Quote Nasdaq, December 10, 2024 at 04:00 pm EST

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B-
surperformance-ratings-light-chart THE-COOPER-COMPANIES-INCMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
99.26USD
Average target price
112.01USD
Spread / Average Target
+12.84%
Consensus

Quarterly revenue - Rate of surprise